PharmaDepth

Company profile

BAXTER INTERNATIONAL INC

NYSE:BAXMedical/Dental Instruments

Drug pipeline (318)

AssetStageRevenueTrialsStatus
ACETAMINOPHENapproved—78approved
ACETIC ACID 0.25% IN PLASTIC CONTAINERapproved—0—
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINERapproved—0—
AMINOCAPROIC ACIDapproved—0—
AMRINONE LACTATEapproved—0—

Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.

Clinical trials (36)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT06842121phase1completed2025-01-272025-05-22Baxter Healthcare CorporationA Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
NCT00358553phase1completed——Baxter Healthcare CorporationA Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin
NCT06842134phase1completed2025-01-272025-05-22Baxter Healthcare CorporationA Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT00508495phase3completed2007-08-012008-03-01Baxter Healthcare CorporationAnalgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain
NCT00406679phase3completed2006-11-012007-10-01Baxter Healthcare CorporationAnalgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solutions in Post-Surgical Dental Pain

FDA applications (235)

ApplicationApprovedTypeApplicantProducts
NDA 2185242026-08-14NDABAXTER HEALTHCARE CORP
ANDA 2084582026-08-06ANDABAXTER HEALTHCARE CORP
ANDA 2198822026-07-28ANDABAXTER HEALTHCARE CORP
ANDA 2167402026-07-08ANDABAXTER HEALTHCARE CORP
ANDA 2178962026-07-02ANDABAXTER HEALTHCARE CORP